Anti-doping
CCES Advisories
July 13, 2010 - Anti-Doping Quick Reference Card available for download
June 30, 2010 - Ottawa, Ontario – Canadian Anti-Doping Rules Up for Review . The Canadian Centre for Ethics in Sport (CCES) is revising the Canadian anti-doping rules, and invites members of the sport community to review and comment on the draft, released today. The 2009 Canadian Anti-Doping Program (CADP) requires rules changes to remain current with the World Anti-Doping Code. Your feedback is vital to the process.
January 5, 2010 - Ottawa, Ontario – Pseudoephedrine on the 2010 Prohibited List.
The Canadian Centre for Ethics in Sport (CCES) would like to remind the
Canadian sport community that the World Anti-Doping Agency (WADA) has
reintroduced pseudoephedrine to the Prohibited List effective January
1, 2010.
October 21, 2009 - Ottawa, Ontario - The 2010 WADA Prohibited List: Summary of Revisions.
The Canadian Centre for Ethics in Sport (CCES) would like to alert the
Canadian sport community that the World Anti-Doping Agency (WADA) has
released the 2010 Prohibited List, which comes into effect January 1,
2010. This advisory details some of the major changes to this year’s
list.
August 18, 2009 - Ottawa, Ontario - CES Issues Warning Against the Use of Geranamine, a Weight Loss Substance, that Can Lead to a Doping Violation.
The Canadian Centre for Ethics in Sport (CCES) would like to warn
athletes subject to doping control that they should NOT take
supplements containing Geranamine, a prohibited stimulant and
fat-burning substance.
August 11, 2009 - Ottawa, Ontario - Blood Sample Collection Integral to Clean Sport in Canada.
The Canadian Centre for Ethics in Sport (CCES) is resuming blood
testing, complementing the use of urine analysis in an increasingly
robust anti-doping program.
_______________________
|
Understanding Your
Responsibilities as an Athlete
|
| |
|
WADA Advisories
November 3, 2009 – Montreal - WADA Publishes Revised International Standard for Therapeutic Use Exemptions. Following approval by its Executive Committee, the World Anti-Doping Agency (WADA) has now published the revised International Standard for Therapeutic Use Exemptions (ISTUE). This Standard will take effect on January 1, 2010.
The ISTUE was revised as a result of the adoption of the 2010 Prohibited List. The ISTUE had to be amended to accommodate some of the changes to the List to be implemented on January 1, 2010, in particular the removal of inhaled salbutamol from the List. This resulted in the deletion of Annex 1 and of the special provision in relation to Beta-2 agonists of the ISTUE.
Under the 2010 List, salbutamol, salmeterol, platelet-derived preparations, and glucocorticosteroids administered by some routes will require a Declaration of Use. In order to avoid frequent changes to the ISTUE, the name of the substances that require a Declaration of Use is no longer included in the ISTUE, but rather is clearly indicated in the List.
Furthermore, in order to simplify the ISTUE, a number of provisions were rewritten or reordered, maintaining however all the key principles of the Standard.
To consult the revised ISTUE, click here.
_______________________
FEI: Declaration of Use (DoU) – NEW!
Some substances included in the list of Prohibited Substances are used
to treat medical conditions frequently encountered in the Athletes
population. They are strictly limited to: glucocorticosteroids used by
non-systemic routes, namely intraarticular, periarticular,
peritendinous, epidural, intradermal injections and inhaled route. For
these substances, no TUE is required. Instead, a Declaration of Use
must be submitted by the Athlete.
Athletes listed in the 2009 FEI REGISTERED TESTING POOL (RTP) must file
their Declaration of Use (DoU) for the abovementioned substances
through the ADAMS program exclusively.
_______________________
Canadian Anti Doping Program 2009
Supplements
Whereabouts Program
Athlete Rights & Responsibilities
International Doping Control
|
